Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Climb Bio Inc (CLYM)

78 + Investors. Track Smart Money conviction in CLYM. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +14
Streak
1Q ▲
Buyers last Q
60%

Smart Money Signals — CLYM

Based on 78 hedge funds · latest filing: 2026 Q1 · updated quarterly

📈

Buying streak — 1 quarter in a row

last 6Q
For 1 consecutive quarter, more hedge funds added CLYM than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
🏔️

At the ownership peak (100% of max)

100% of all-time peak
78 hedge funds hold CLYM right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.
📶

Steady growth — +4% more funds vs a year ago

fund count last 6Q
+3 new funds entered over the past year (+4% YoY). Gradual, steady growth in institutional ownership is generally a healthy signal — not a speculative rush, but consistent conviction.
🟢

More buyers than sellers — 60% buying

52 buying34 selling
Last quarter: 52 funds were net buyers (27 opened a brand new position + 25 added to an existing one). Only 34 were sellers (21 trimmed + 13 sold completely). A clear majority buying is a strong confirmation signal.
📈

More new buyers each quarter (+10 vs last Q)

new funds entering per quarter
Funds opening a new CLYM position: 18 → 11 → 17 → 27. A growing influx of new institutional buyers means the asset is still gathering momentum — the consensus hasn't fully saturated yet.
🔄

Mostly new holders — 38% entered in last year

■ 23% conviction (2yr+) ■ 38% medium ■ 38% new
Only 18 funds (23%) have held >2 years. The majority of current holders are relatively new to the position. New holders tend to sell faster when prices drop — a shallow conviction base that could amplify any sell-off.
💰

Value +40% but shares only +4% — price-driven

Value
+39%
Shares
+4%
Last quarter: the total dollar value of institutional holdings rose +40%, but actual share count only changed +4%. The gap is explained by the stock's price rising — not new buying. Strong value growth with weak share growth means the rally is price momentum, not fresh institutional demand.
🚀

Acceleration phase — new buyers rushing in

15 → 18 → 11 → 17 → 27 new funds/Q
New funds entering each quarter: 18 → 11 → 17 → 27. The pace of institutional discovery is accelerating sharply. This is the 'hot idea' phase — the thesis is being passed from fund to fund. You are not late — the accumulation wave is still building.
📊

Mixed cohorts — 36% veterans, 38% new entrants

■ 36% veterans ■ 26% 1-2yr ■ 38% new
Of 80 current holders: 29 (36%) held 2+ years, 21 held 1–2 years, 30 (38%) entered in the past year. Balanced distribution — some institutional memory, some recent momentum buyers.
📋

Smaller funds dominant — 13% AUM from top-100

13% from top-100 AUM funds
22 of 78 holders rank in the top 100 by AUM, but together hold only 13% of total institutional value. The stock is held primarily by smaller and mid-sized funds.
4.0
out of 10
Moderate Exit Risk
Exit risk score 4.0/10 — some crowding factors present, but no critical concentration. Watch ownership trend over the next 1–2 quarters for direction.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — CLYM

In 2026 Q1, 52 hedge funds were net buyers of CLYM (27 opened a new position, 25 added to an existing one), while 34 reduced or exited (21 trimmed, 13 sold completely) — a 60% buyer ratio, indicating clear institutional accumulation. Net fund flow last quarter: +14 funds (more new holders than closures). Total institutional holders: 78.

Hedge Fund Ownership: CLYM

How many hedge funds hold CLYM — quarterly history vs. share price
Quarterly hedge fund ownership of CLYM vs. share price

Market Analysis: CLYM

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: CLYM

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy Climb Bio Inc (CLYM) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much CLYM has moved relative to its sector benchmark (XLV) since the 2026 Q1 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End March 31, 2026 · 79d ago
CLYM
+67.2%
XLV
+2.1%

CLYM outperformed XLV by +65.1% since March 31, 2026.

Since 13F Filing Date May 15, 2026 · 34d ago
CLYM
+6.0%
XLV
+3.2%

Since the filing became public, CLYM outperformed XLV by +2.8% .

Interpretation: The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference. Learn more →

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

7 top-rated funds 1 high-conviction
Consensus
3.9
/ 10
breadth
×
Elite
1.3
/ 10
conviction
Hedge Fund Positioning: CLYM
78 + Investors

Track Smart Money conviction in CLYM. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q1) Prior (2025 Q4) Change
Funds Holding 78 64 21.88%
13F Shares 32M 31M 4.05%
Total Value $209M $150M 39.6%
New Positions 27 17 +10
Increased Positions 26 21 +5
Closed Positions 13 19 -6
Reduced Positions 20 20 -
Total Calls 2 0 100%
Total Puts 0 0 -
PUT/CALL Ratio 0.0 0.0 Bullish

Statistics: CLYM

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

78 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in CLYM. Verified SEC 13F-HR filings.

QUARTER:
Top 25 CLYM holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Great Point Partners LLC 2.10% 1,334,130 $9.1M
2 MPM BioImpact LLC 1.37% 2,593,439 $17.8M
3 Verdad Advisers, LP 1.11% 144,540 $990K
4 Superstring Capital Management LP 0.97% 199,209 $1.4M
5 Ra Capital Management, L.P. 0.82% 11,300,939 $77.4M
6 Peapod Lane Capital LLC 0.61% 108,878 $740K
7 Silverarc Capital Management, LLC 0.48% 684,908 $4.7M
8 Sphera Funds Management LTD. 0.46% 419,247 $2.9M
9 Kynam Capital Management, LP 0.42% 1,003,341 $6.9M
10 Braidwell LP 0.35% 1,529,675 $10.5M
11 Diadema Partners LP 0.33% 286,126 $2.0M
12 NAN FUNG TRINITY (HK) Ltd 0.32% 420,517 $2.9M
13 Seven Fleet Capital Management LP 0.28% 130,654 $895K
14 Affinity Asset Advisors, LLC 0.25% 700,000 $4.8M
15 ADAR1 Capital Management, LLC 0.24% 597,662 $4.1M
16 ArchPoint Investors 0.20% 121,400 $832K
17 Persistent Asset Partners Ltd 0.18% 72,325 $495K
18 Arrowpoint Investment Partners (Singapore) Pte. Ltd. 0.15% 24,590 $168K
19 Longaeva Partners L.P. 0.06% 217,768 $1.5M
20 683 Capital Management, LLC 0.03% 90,000 $616K
21 Driehaus Capital Management LLC 0.03% 600,946 $4.1M
22 Fox Run Management, L.L.C. 0.02% 19,287 $126K
23 Diametric Capital, LP 0.02% 11,218 $77K
24 Bridgeway Capital Management, LLC 0.02% 134,300 $920K
25 Boothbay Fund Management, LLC 0.01% 92,297 $632K
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Climb Bio Inc (CLYM)

What does the Smart Money Trend signal show for CLYM?

Buying streak — 1 quarter in a row: For 1 consecutive quarter, more hedge funds added CLYM than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for CLYM?

More buyers than sellers — 60% buying: Last quarter: 52 funds were net buyers (27 opened a brand new position + 25 added to an existing one). Only 34 were sellers (21 trimmed + 13 sold completely). A clear majority buying is a strong confirmation signal.

What is the fund quality score for CLYM holders?

Smaller funds dominant — 13% AUM from top-100: 22 of 78 holders rank in the top 100 by AUM, but together hold only 13% of total institutional value. The stock is held primarily by smaller and mid-sized funds.

How long have hedge funds held CLYM?

Mostly new holders — 38% entered in last year: Only 18 funds (23%) have held >2 years. The majority of current holders are relatively new to the position. New holders tend to sell faster when prices drop — a shallow conviction base that could amplify any sell-off.

Is it too late to buy Climb Bio Inc (CLYM) following the 2026 Q1 hedge fund 13F filings?

As of today, CLYM has moved +6.0% since the 2026 Q1 13F filing date (May 15, 2026), compared to +3.2% for the XLV sector ETF — an outperformance of +2.8%. Since the quarter end (March 31, 2026), CLYM has gained +67.2% vs +2.1% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →